Stay updated on BeGeRN Clinical Trial
Sign up to get notified when there's something new on the BeGeRN Clinical Trial page.

Latest updates to the BeGeRN Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedUpdate: version bump to v3.2.0, added government-operating-status notice, and new resource topic on malignant lymphoma (large B-cell, diffuse).SummaryDifference5%

- Check26 days agoChange DetectedUpgrade to v3.1.0 with removal of the Diffuse large B-cell lymphoma resource and update from v3.0.2 to v3.1.0.SummaryDifference0.7%

- Check40 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, specifically Saint Petersburg, Russia, along with various medical terms related to diffuse large B-cell lymphoma and associated treatments. Notably, several previous terms and references have been removed, including specific drug names and related topics.SummaryDifference8%

- Check69 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to BeGeRN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BeGeRN Clinical Trial page.